Part Details | CISPLATIN INJECTION
6505-01-314-4270
Alternate Parts: 3400957615772, PLATINOLAQ, PLATINOL-AQ, NDC00015322022, NDC00015-3220-22, 6505-01-314-4270, 01-314-4270, 6505013144270, 013144270
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | JAN 30, 1990 | 01-314-4270 | 45834 ( CISPLATIN INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-314-4270
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 3400957615772 | FB5J2 | ACCORD HEALTHCARE FRANCE SAS |
| PLATINOL-AQ | 29398 | MEAD JOHNSON & COMPANY, LLCDBA MEAD JOHNSON NUTRITION |
| NDC00015-3220-22 | 29398 | MEAD JOHNSON & COMPANY, LLCDBA MEAD JOHNSON NUTRITION |
Technical Data | NSN 6505-01-314-4270
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| SPECIAL FEATURES | 50 MG CISPLATIN EQUIVALENT PREDILUTED IN 50 ML OF 0.9 PCT SODIUM CHLORIDE; STERILE; AQUEOUS; SINGLE-DOSE 50 ML FILL VIAL W/A RATED CAPACITY OF NOT LESS THAN 100 ML W/HANGING DEVICE WHICH ALLOWS THE BT TO BE HUNG FOR INTERMITTANT INTRAVENOUS ADMINISTRATION; FOR USE W/STOCKLISTED INTRAVENOUS INJECTION SETS |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PLATINOL-AQ |